Drospirenone/EE 3/20 (Apo) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: inert substance, drospirenone + ethinylestradiol
Brand name
(ARTG)
: APO-DROSPIRENONE/EE 3/20 drospirenone 3 mg and ethinylestradiol 20 microgram film coated tablet blister packWhat this medicine is used for
(ARTG)
This medicine is indicated for use as: an oral contraceptive. treatment of moderate acne vulgaris in women who seek oral contraception. treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of drospirenone 3 mg /ethinylestradiol 20 µg for PMDD was not assessed beyond 3 cycles. Drospirenone 3 mg /ethinylestradiol 20 µg has not been evaluated for treatment of PMS (premenstrual syndrome), see section 5.1 Pharmacodynamic Properties - Clinical trials.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Tablet, film coated
- Oral
- Plain, round, pink, film coated tablets
Component :
- Tablet, film coated
- Oral
- Plain, round, white, film coated tablets
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 21 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 28s (24 Active Tablets + 4 Placebo Tablets) pack
- 3 x 28s (24 Active Tablets + 4 Placebo Tablets) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient drospirenone + ethinylestradiol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
